Date Fruit Extract / Poly Cancer Research Results

DFE, Date Fruit Extract: Click to Expand ⟱
Features:
Dates (the fruit of Phoenix dactylifera) have been increasingly studied for their potential anticancer and cancer-preventive properties, mainly due to their rich phytochemical content and strong antioxidant activity.
Dates contain a broad spectrum of bioactive compounds linked to cancer prevention:
-Phenolic acids – e.g., ferulic acid, gallic acid, caffeic acid, and p-coumaric acid
-Flavonoids – e.g., quercetin, luteolin, apigenin
-Carotenoids – e.g., β-carotene, lutein
-Tannins, saponins, and sterols
-Dietary fiber and polysaccharides
These compounds have antioxidant, anti-inflammatory, and antiproliferative effects.

Date fiber and polyphenols foster beneficial gut bacteria (e.g., Bifidobacterium, Lactobacillus) that produce short-chain fatty acids (SCFAs), which protect the colon and may lower colon cancer risk.

Date Fruit Extract — a non-standardized botanical extract prepared from the edible fruit pulp of Phoenix dactylifera L., including cultivars such as Ajwa, Medjool, Hallawi, Sukkari, and others. It is classified as a complex food-derived phytochemical mixture rather than a single defined drug or active pharmaceutical ingredient. The standard abbreviation is DFE. Principal constituents vary substantially with cultivar, ripeness, processing, and extraction solvent, but commonly include phenolic acids such as gallic, ferulic, caffeic, protocatechuic, and p-coumaric acids; flavonoids such as quercetin, luteolin, apigenin, catechin, and epicatechin derivatives; carotenoids; condensed tannins; polysaccharides; and dietary fiber. Date fruit, date seed, leaf, pollen, and nanoparticle preparations are compositionally distinct and should not be treated as interchangeable with fruit-pulp extract.

Primary mechanisms (ranked):

  1. Induction of mitochondrial apoptosis in susceptible cancer cells, involving mitochondrial membrane depolarization, BAX/BCL-2 imbalance, caspase activation, and DNA fragmentation.
  2. Suppression of cancer-cell proliferation through cell-cycle arrest, with reported accumulation in G1 or G2/M phases depending on the extract, concentration, and tumor model.
  3. Redox modulation, including antioxidant protection in normal tissues but concentration-dependent ROS and mitochondrial ROS elevation in some cancer-cell models.
  4. Modulation of p53-associated stress and apoptotic signaling in responsive tumor cells.
  5. Anti-inflammatory activity through suppression of NF-κB-associated inflammatory signaling and inflammatory mediators, although direct tumor-specific evidence is limited.
  6. Secondary modulation of PI3K/AKT and related survival signaling, reported inconsistently and not established as a universal mechanism.
  7. Potential suppression of migration, clonogenic survival, angiogenic signaling, and tumor growth in selected preclinical models.
  8. Indirect colon-health effects through fermentable fiber and polyphenol interactions with the gut microbiota and production of short-chain fatty acids.

Bioavailability / PK relevance: No clinically validated pharmacokinetic profile exists for DFE as a standardized anticancer agent. Its polyphenols undergo incomplete intestinal absorption, extensive phase-II conjugation, microbial metabolism, and rapid systemic clearance. Consequently, circulating concentrations of individual parent compounds are generally much lower than concentrations used for direct cancer-cell cytotoxicity. Local gastrointestinal exposure and microbial metabolites may be more biologically relevant than systemic exposure after ordinary date consumption.

In-vitro vs systemic exposure relevance: Most antiproliferative studies use crude solvent fractions at tens to hundreds of micrograms per millilitre. These concentrations cannot be directly equated with plasma exposure after eating dates or taking an unstandardized extract. Extract-specific cytotoxic effects may reflect concentrated mixtures, solvent-selective enrichment, or interactions among multiple constituents. Common in-vitro exposures probably exceed achievable systemic concentrations from dietary intake.

Clinical evidence status: Preclinical. Evidence consists primarily of cell-culture studies, limited animal experiments, compositional studies, and small human dietary studies evaluating metabolic, inflammatory, or gastrointestinal outcomes. No randomized controlled oncology trial has established DFE as a cancer treatment, adjunctive anticancer therapy, radiosensitizer, or chemotherapy sensitizer. Date fruit and date-derived extracts are not approved by Health Canada, the FDA, or the EMA as anticancer drugs.

Safety and deployment: Whole dates are conventional foods and are generally well tolerated, but they contain substantial carbohydrate and sugar and may require portion control in people with impaired glycemic regulation. Extracts may differ markedly from the food in concentration, solvent residues, composition, and contaminant risk. Clinical interaction data with chemotherapy, anticoagulants, endocrine therapies, or targeted agents are inadequate. DFE should not be assumed to protect normal tissue selectively or improve anticancer treatment efficacy without direct combination studies.

Date Fruit Extract Mechanistic Profile

Rank Pathway / Axis Cancer Cells Normal Cells TSF Primary Effect Notes / Interpretation
1 Mitochondrial apoptosis MMP ↓; BAX ↑; BCL-2 ↓; caspase-3 ↑; apoptosis ↑ Apoptotic injury often ↓ in oxidative-damage models R, G Programmed cancer-cell death Best-supported direct anticancer mechanism, but demonstrated mainly with concentrated Ajwa or solvent-fraction extracts in vitro.
2 Cell-cycle control Proliferation ↓; G1 or G2/M arrest ↑ (model-dependent) ↔ G Cytostasis Cell-cycle phase varies by tumor line, cultivar, solvent fraction, concentration, and exposure duration.
3 ROS and mitochondrial oxidative stress ROS ↑; mitochondrial ROS ↑ (dose-dependent) ROS ↓; lipid peroxidation ↓; antioxidant capacity ↑ P, R Context-dependent redox modulation Cancer-cell pro-oxidant activity has been reported, while antioxidant protection predominates in normal-tissue injury models. Tumor selectivity is not clinically established.
4 p53 stress response p53 ↑; apoptotic signaling ↑ (model-dependent) ↔ R, G Stress-mediated growth suppression Reported in selected models and should not be generalized to p53-deficient or mutant-p53 tumors.
5 NF-κB inflammatory signaling NF-κB-associated survival and inflammation ↓ (limited evidence) Inflammatory signaling ↓ R, G Anti-inflammatory modulation More consistently supported in inflammatory or tissue-injury systems than in direct oncology experiments.
6 PI3K and AKT survival signaling PI3K/AKT ↓ (context-dependent) ↔ or AKT support ↑ in injury models R, G Survival-pathway suppression Not consistently measured across DFE studies and may partly reflect activities of individual phenolic constituents.
7 Clonogenic survival and tumor growth Colony formation ↓; tumor-cell burden ↓ in limited models ↔ G Long-term growth inhibition Evidence is substantially weaker than for established anticancer agents and remains extract-specific.
8 Migration and invasion Migration ↓; invasion-related signaling possibly ↓ ↔ G Potential antimetastatic activity Limited mechanistic data; MMP and epithelial-mesenchymal transition effects require further confirmation.
9 Angiogenic signaling VEGF-associated signaling possibly ↓ ↔ G Potential angiogenesis suppression Sparse evidence and not established as a primary effect of fruit-pulp extract.
10 NRF2 antioxidant response NRF2 modulation mixed (context-dependent) NRF2 and antioxidant enzymes ↑ R, G Secondary cytoprotective response NRF2 activation may protect normal tissues but could theoretically support antioxidant resistance in some cancers. Direct DFE tumor data are insufficient to define the net effect.
11 Gut microbiota and short-chain fatty acids Indirect colon-environment modulation Beneficial bacterial growth ↑; fermentation products ↑ G Local gastrointestinal and metabolic effect Human dietary evidence supports microbiota and bowel-environment effects more strongly than systemic anticancer activity.
12 Clinical Translation Constraint Effective exposure uncertain; extract composition heterogeneous Food-level tolerance generally favorable G Limits clinical interpretation Major constraints include cultivar and solvent variability, absent extract standardization, low systemic polyphenol exposure, high in-vitro concentrations, limited animal oncology evidence, and no controlled cancer trials.

TSF: P: 0–30 min    R: 30 min–3 hr    G: >3 hr
Poly, polyphenols: Click to Expand ⟱
Source:
Type: Ingredient

Ingredient

Common Polyphenols and Their Potential Effects in Cancer and Alzheimer’s Disease

Polyphenols are plant-derived compounds with antioxidant, anti-inflammatory, cell-signalling, and gene-regulatory effects. Most evidence is preclinical; human clinical evidence varies considerably by compound.

Polyphenol Common Sources Basic Potential Effect Against Cancer Basic Potential Effect in Alzheimer’s Disease (AD)
Curcumin Turmeric May inhibit NF-κB, STAT3, PI3K/Akt, angiogenesis, invasion, and inflammatory signalling; may promote apoptosis and cell-cycle arrest. May reduce neuroinflammation, oxidative stress, amyloid-β aggregation, and tau-related pathology; limited by poor oral bioavailability.
Resveratrol Grapes, red wine, peanuts, berries May activate apoptosis and inhibit proliferation, angiogenesis, metastasis, NF-κB, and PI3K/Akt signalling. May activate SIRT1 and AMPK, support mitochondrial function, and reduce neuroinflammation and amyloid-related toxicity.
Quercetin Onions, apples, capers, berries May induce apoptosis, inhibit proliferation, reduce oxidative stress, and modulate PI3K/Akt, MAPK, p53, and NF-κB pathways. May reduce oxidative stress, microglial activation, amyloid toxicity, and mitochondrial dysfunction.
Epigallocatechin gallate (EGCG) Green tea May inhibit proliferation, angiogenesis, invasion, DNMT activity, NF-κB, EGFR, and PI3K/Akt signalling; may promote apoptosis. May inhibit amyloid-β aggregation, promote less-toxic amyloid structures, reduce oxidative stress, and support neuronal survival.
Kaempferol Kale, spinach, broccoli, tea, beans May promote apoptosis and inhibit proliferation, angiogenesis, epithelial–mesenchymal transition, PI3K/Akt, and inflammatory pathways. May reduce oxidative stress, neuroinflammation, amyloid toxicity, and neuronal apoptosis.
Apigenin Parsley, celery, chamomile May induce apoptosis and cell-cycle arrest and inhibit NF-κB, STAT3, PI3K/Akt, angiogenesis, and metastasis. May reduce microglial activation, oxidative stress, amyloid toxicity, and inflammatory cytokine production.
Luteolin Celery, parsley, peppers, thyme May inhibit proliferation, metastasis, angiogenesis, NF-κB, STAT3, MAPK, and PI3K/Akt signalling and promote apoptosis. May suppress neuroinflammation, microglial activation, oxidative damage, amyloid accumulation, and tau phosphorylation.
Fisetin Strawberries, apples, persimmons, onions May induce apoptosis and inhibit proliferation, invasion, PI3K/Akt, mTOR, NF-κB, and epithelial–mesenchymal transition. May support synaptic function, reduce neuroinflammation and oxidative stress, and act as a senolytic compound in some experimental models.
Myricetin Berries, grapes, tea, walnuts May inhibit proliferation, migration, angiogenesis, and oxidative stress and promote apoptosis. May inhibit amyloid-β aggregation, reduce oxidative injury, and modulate inflammatory and neuronal-survival pathways.
Genistein Soybeans and soy products May inhibit tyrosine kinases, proliferation, angiogenesis, and hormone-dependent cancer signalling; may induce apoptosis. May reduce oxidative stress and neuroinflammation and support mitochondrial and estrogen-receptor-mediated neuronal protection.
Daidzein Soybeans and legumes May modulate estrogen receptors, inhibit proliferation, and promote apoptosis in some hormone-responsive cancers. May provide estrogen-receptor-mediated neuroprotection and reduce oxidative and inflammatory damage.
Delphinidin Blueberries, blackcurrants, purple grapes May inhibit proliferation, angiogenesis, invasion, and inflammatory signalling and promote apoptosis. May reduce oxidative stress, neuroinflammation, and amyloid-associated neuronal injury.
Cyanidin-3-glucoside Berries, cherries, purple corn, black rice May reduce oxidative stress, inflammation, proliferation, and metastatic signalling and promote apoptosis. May support memory and synaptic function and reduce oxidative stress, neuroinflammation, and amyloid-related damage.
Pelargonidin Strawberries, raspberries, red radish May inhibit inflammatory signalling and proliferation and promote apoptosis in experimental cancer models. May reduce oxidative stress and neuroinflammation and protect neurons from amyloid-associated injury.
Proanthocyanidins Grape seed, cocoa, cranberries, apples May inhibit proliferation, angiogenesis, invasion, and inflammatory signalling and promote apoptosis. May reduce oxidative stress, amyloid aggregation, neuroinflammation, and synaptic damage.
Ellagic acid Pomegranates, raspberries, strawberries, walnuts May induce apoptosis and cell-cycle arrest and inhibit proliferation, angiogenesis, inflammation, and DNA damage. May reduce oxidative stress, neuroinflammation, amyloid toxicity, and neuronal apoptosis.
Urolithin A Gut-microbial metabolite of ellagitannins from pomegranate, berries, and walnuts May inhibit proliferation and inflammation and promote apoptosis; effects vary by cancer type. May improve mitophagy, mitochondrial quality control, and cellular stress resistance; potentially relevant to brain ageing.
Gallic acid Tea, grapes, berries, sumac, gallnuts May promote apoptosis and inhibit proliferation, migration, angiogenesis, and inflammatory signalling. May reduce oxidative stress, neuroinflammation, amyloid toxicity, and cholinergic dysfunction.
Caffeic acid Coffee, herbs, fruits, vegetables May inhibit proliferation, inflammation, invasion, and angiogenesis and promote apoptosis. May reduce oxidative stress, neuroinflammation, amyloid toxicity, and neuronal damage.
Caffeic acid phenethyl ester (CAPE) Propolis Potent experimental NF-κB inhibitor; may suppress proliferation, invasion, inflammation, and angiogenesis and promote apoptosis. May suppress neuroinflammation, oxidative stress, microglial activation, and neuronal apoptosis.
Chlorogenic acid Coffee, blueberries, apples, potatoes May reduce oxidative stress, inflammation, proliferation, migration, and angiogenesis. May support glucose metabolism and reduce oxidative stress, neuroinflammation, amyloid toxicity, and cognitive impairment.
Ferulic acid Whole grains, rice bran, oats, seeds May reduce oxidative damage and inflammation and inhibit proliferation, angiogenesis, and metastatic signalling. May inhibit amyloid aggregation, reduce oxidative stress and neuroinflammation, and protect synaptic and neuronal function.
Rosmarinic acid Rosemary, lemon balm, sage, basil, perilla May inhibit proliferation, inflammation, migration, and angiogenesis and promote apoptosis. May reduce amyloid aggregation, oxidative stress, microglial activation, and inflammatory cytokines.
Chicoric acid / Cichoric acid Echinacea, chicory, dandelion, lettuce May reduce inflammation, oxidative stress, proliferation, and metastatic signalling; cancer evidence remains mainly preclinical. May reduce neuroinflammation, oxidative stress, amyloid-related injury, and cognitive impairment in experimental models.
Oleuropein Olive leaves and olives May inhibit proliferation, angiogenesis, invasion, and inflammatory signalling and induce apoptosis. May inhibit amyloid aggregation, improve autophagy, and reduce oxidative stress and neuroinflammation.
Hydroxytyrosol Olives and extra-virgin olive oil May reduce oxidative DNA damage, inflammation, proliferation, and metastatic signalling. May protect mitochondria and neurons and reduce oxidative stress, neuroinflammation, amyloid toxicity, and tau-related damage.
Tyrosol Olives, olive oil, wine May provide antioxidant and anti-inflammatory effects, although direct anticancer activity is generally weaker than hydroxytyrosol. May support neuronal antioxidant defence and reduce inflammatory and oxidative injury.
Honokiol Magnolia bark May inhibit STAT3, NF-κB, PI3K/Akt, angiogenesis, stem-like cancer cells, and metastasis and promote apoptosis. May reduce neuroinflammation, oxidative stress, amyloid toxicity, and neuronal apoptosis; may support GABAergic signalling.
Magnolol Magnolia bark May inhibit proliferation, migration, angiogenesis, NF-κB, and PI3K/Akt signalling and induce apoptosis. May reduce oxidative stress, microglial activation, neuroinflammation, and amyloid-associated toxicity.
Pterostilbene Blueberries and grapes Resveratrol-related compound with greater lipophilicity; may inhibit proliferation, metastasis, inflammation, and PI3K/Akt signalling. May activate SIRT1 and antioxidant pathways and reduce neuroinflammation, oxidative stress, and amyloid-related injury.

Frequently Modulated Cancer Targets and Pathways

NF-κB, STAT3, PI3K/Akt/mTOR, MAPK/ERK, Wnt/β-catenin, p53, BCL-2, BAX, caspases, VEGF, HIF-1α, MMP-2, MMP-9, Nrf2/HO-1, cyclins, CDKs, AMPK, SIRT1, and epithelial–mesenchymal transition pathways.

Frequently Modulated Alzheimer’s Disease Targets and Pathways

Amyloid-β production and aggregation, BACE1, APP processing, tau phosphorylation, GSK-3β, acetylcholinesterase, microglial activation, NF-κB, NLRP3 inflammasome, Nrf2/HO-1, SIRT1, AMPK, mitochondrial function, mitophagy, synaptic plasticity, oxidative stress, and inflammatory cytokines.

Evidence note: These effects describe commonly reported mechanisms from cell, animal, and limited human studies. They do not establish that the compounds prevent or treat cancer or Alzheimer’s disease in humans. Bioavailability, metabolism, dose, cancer type, disease stage, and interactions with medications can substantially alter their effects.



Scientific Papers found: Click to Expand⟱
6666- DFE,    The impact of date palm fruits and their component polyphenols, on gut microbial ecology, bacterial metabolites and colon cancer cell proliferation
- in-vitro, Colon, Caco-2
*Fibre↑, *Poly↑, *other↝, *QC↑, *Api↑, *Myr↑, *LT↑, TumCP↓, *GutMicro↑, *Inflam↓, *antiOx↑,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:


Migration(tgid=13) ⓘ

TumCP↓, 1,  
Total Targets: 1

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↑, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

other↝, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

Inflam↓, 1,  

Clinical Biomarkers(tgid=22) ⓘ

GutMicro↑, 1,  

Ingredients & Constituents(tgid=25) ⓘ

Api↑, 1,   Fibre↑, 1,   LT↑, 1,   Myr↑, 1,   Poly↑, 1,   QC↑, 1,  
Total Targets: 10

Scientific Paper Hit Count for: Poly, polyphenols
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:371  Target#:1517  State#:%  Dir#:2
  wNotes=0  sortOrder:rid,rpid

 

Home Page